May 2 (Bloomberg) — CVS Caremark Corp., the largest provider of prescription drugs in the U.S., posted first-quarter profit that fell short of estimates as cold weather and a mild flu season hurt sales. The company reaffirmed its 2014 forecast.
Earnings, excluding one-time items, of $1.02 a share missed by 2 cents the average of 21 analyst estimates compiled by Bloomberg. Full-year profit is still expected to be $4.36 to $4.50 a share, the the Woonsocket, Rhode Island-based company said in a statement today.
The severe winter weather kept consumers out of storefront pharmacies during the quarter, reducing sales of prescription drugs and consumer goods. CVS joined Express Scripts Holding Co., its biggest rival in the pharmacy benefit management business, in receiving a subpoena from the U.S. Attorney's Office for the District of Rhode Island, CVS Chief Executive Officer Larry Merlo said.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
